Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-12-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9378
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1376
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9822530-Abortifacient Agents, Nonsteroidal,
pubmed-meshheading:9822530-Abortifacient Agents, Steroidal,
pubmed-meshheading:9822530-Abortion, Induced,
pubmed-meshheading:9822530-Adult,
pubmed-meshheading:9822530-Female,
pubmed-meshheading:9822530-Humans,
pubmed-meshheading:9822530-Mifepristone,
pubmed-meshheading:9822530-Misoprostol,
pubmed-meshheading:9822530-Pregnancy
|
pubmed:year |
1998
|
pubmed:articleTitle |
Mifepristone-misoprostol medical abortion: who will use it and why?
|
pubmed:publicationType |
Letter
|